Co-Pays For GLP-1 Weight Loss Drugs To Rise If They’re Even Covered

GLP-1 weight loss drugs like Ozempic, Zepbound and Wegovy are the biggest contributor to rising prescription spending. And that will trigger co-payments to rise.
Source
Forbes
Opens original article in a new tab



